528
Views
12
CrossRef citations to date
0
Altmetric
Review

An Overview of a Novel, Water-Soluble Undenatured Type II Collagen (NEXT-II)

, PhD, FACN, , PhD, FACN & , MS
Pages 255-262 | Received 24 Feb 2014, Accepted 25 Apr 2014, Published online: 09 Mar 2015

REFERENCES

  • Richardson DC, Schoenherr WD, Zicker SC: Nutritional management of osteoarthritis. Vet Clin North Am Small Anim Pract 27:883–911, 1997.
  • Bellamy N, Carr A, Dougados M, Shea B, Wells G: Towards a definition of “difference” in osteoarthritis. J Rheumatol 28:427–430, 2001.
  • Goldring MB: Anticytokine therapy for osteoarthritis. Expert Opin Biol Ther 1:817–829, 2001.
  • de Seny D, Cobraiville G, Charlier E, Neuville S, Esser N, Malaise D, Malaise O, Calvo F, Relic B, Malaise MG: Acute-phase serum amyloid a in osteoarthritis: regulatory mechanism and proinflammatory properties. PLoS One 8:e66769, 2013.
  • Shen CL, Smith BJ, Lo DF, Chyu MC, Dunn DM, Chen CH, Kwun IS: Dietary polyphenols and mechanisms of osteoarthritis. J Nutr Biochem 23:1367–1377, 2012.
  • Arthritis Foundation. Available at: http://www.arthritis.org/files/images/newsroom/media-kits/Rheumatoid_Arthritis_Fact_Sheet.pdf
  • Hootman JM, Helmick CG Projection of U.S. prevalence of arthritis and associated activity limitations. Arthritis Rheum 54:226–229,2006.
  • Bagchi D, Moriyama H, Raychaudhuri SP (eds): “Arthritis Pathophysiology, Prevention and Therapeutics.” Boca Raton, FL: CRC Press/Taylor & Francis Group, 2011.
  • Eaton CB: Obesity as a risk factor for osteoarthritis: mechanical versus metabolic. Med Health R I 87:201–204, 2004.
  • Hielm-Björkman AK, Kuusela E, Liman A, Markkola A, Saarto E, Huttunen P, Leppäluoto J, Tulamo RM, Raekallio M: Evaluation of methods for assessment of pain associated with chronic osteoarthritis in dogs. J Am Vet Med Assoc 222:1552–1558, 2003.
  • Bitton R: The economic burden of osteoarthritis. Am J Manag Care 15:S230–S235, 2009.
  • Berenbaum F, Grifka J, Brown JP, Zacher J, Moore A, Krammer G, Dutta D, Sloan VS: Efficacy of lumiracoxib in osteoarthritis: a review of nine studies. J Int Med Res 33:21–41, 2005.
  • Sarzi-Puttini P, Cimmino MA, Scarpa R, Caporali R, Parazzini F, Zaninelli A, Atzeni F, Canesiet B: Osteoarthritis: an overview of the disease and its treatment strategies. Semin Arthritis Rheum 35:1–10, 2005.
  • Goggs R, Vaughan-Thomas A, Clegg PD, Cater SD, Innes JF, Mobasheri A, Shakibaei M, Schwab W, Bondy CA: Nutraceutical therapies for degenerative joint diseases: a critical review. Crit Rev Food Sci Nutr 45:145–164, 2005.
  • Yoshinari O, Ann Marone P, Moriyama H, Bagchi M, Shiojima Y: Safety and toxicological evaluation of a novel, water-soluble undenatured type II collagen. Toxicol Mech Methods 23:491–499, 2013.
  • Yoshinari O, Shiojima Y, Moriyama H, Shinozaki J, Nakane T, Masuda K, Bagchi M: Effects of water-soluble undenatured type II collagen on collagen-induced arthritic mice. J Med Food 16:1039–1045, 2013.
  • Food and Drug Administration: “Good Laboratory Practices (GLP) for Non-clinical Laboratory Studies.” Washington, DC: U.S. Food and Drug Administration, 1987.
  • Organization for Economic Cooperation and Development: “Principles of Good Laboratory Practice.” Paris: Organization for Economic Cooperation and Development, 1998.
  • Bancroft JD, Steven A: “Theory and Practice of Histological Techniques.” 3rd ed. New York: Churchill Livingstone, 1990.
  • Yeates JW: Maximizing canine welfare in veterinary practice and research: a review. Vet J 192:272–278, 2012.
  • Draize JH, Woodward G, Calvery HO: Methods for the study of irritation and toxicity of substances applied topically to the skin and mucous membrane. J Pharm Exp Ther 82:377–390, 1994.
  • Kay JH, Calandra JC: Interpretation of eye irritation tests. J Soc Cosmet Chem 13:281–289, 1962.
  • Maron DM, Ames BN: Revised methods for the Salmonella mutagenicity test. Mutat Res 113:173–215, 1983.
  • Ames BN, McCann J, Yamasaki E: Methods for the Salmonella mutagenicity test. In “Handbook of Mutagenicity Test Procedures.” Philadelphia: Elsevier, pp 1–17, 1977.
  • Barnett ML, Kremer JM, St Clair EW, Clegg DO, Furst D, Weisman M, Fletcher MJ, Chasan-Taber S, Finger E, Morales A, Le CH: Treatment of rheumatoid arthritis with oral type II collagen. Results of a multicenter, double-blind, placebo-controlled trial. Arthritis Rheum 41:290–297, 1998.
  • Wei W, Zhang LL, Xu JH, Xiao F, Bao CD, Ni LQ, Li XF, Wu YO, Sun LY, Zhang RH, Sun BL, Xu SQ, Liu S, Zhang W, Shen J, Liu HX, Wang RC: A multicenter, double-blind, randomized, controlled phase III clinical trial of chicken type II collagen in rheumatoid arthritis. Arthritis Res Ther 11:R180, 2009.
  • D'Altilio M, Peal A, Alvey M, Simms C, Curtsinger A, Gupta RC, Canerdy TD, Goad JT, Bagchi M, Bagchi D: Therapeutic efficacy and safety of undenatured type II collagen singly or in combination with glucosamine and chondroitin in arthritic dogs. Toxicol Mech Methods 17:189–196, 2007.
  • Crowley DC, Lau FC, Sharma P, Evans M, Guthrie N, Bagchi M, Bagchi D, Dey DK, Raychaudhuri SP: Safety and efficacy of undenatured type II collagen in the treatment of osteoarthritis of the knee: a clinical trial. Int J Med Sci 6:312–321, 2009.
  • Moradi B, Schnatzer P, Hagmann S, Rosshirt N, Gotterbaum T, Kretzer JP, Thomsen M, Lorenz HM, Zeifang F, Tretter T: CD4+CD25+/highCD127low/- regulatory T cells are enriched in rheumatoid arthritis and osteoarthritis joints—analysis and frequency and phenotype in synovial membrane, synovial fluid and peripheral blood. Arthritis Res Ther16:R97, 2014.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.